1. Signaling Pathways
  2. Apoptosis
  3. Bcl-2 Family

Bcl-2 Family (Bcl-2蛋白家族)

Bcl-2 是一个进化相关的蛋白质家族。这些蛋白质控制线粒体外膜通透性 (MOMP),可以是促凋亡的(Bax、Bad、Bak 和 Bok 等),也可以是抗凋亡的(包括 Bcl-2 本身、Bcl-xL 和 Bcl-w 等)。迄今为止,Bcl-2 家族中已知的基因共有 25 个。编码属于该家族的蛋白质的人类基因包括:Bak1、Bax、Bal-2、Bok、Mcl-1。

Bcl-2 is a family of evolutionarily related proteins. These proteins govern mitochondrial outer membrane permeabilization (MOMP) and can be either pro-apoptotic (Bax, Bad, Bak and Bok among others) or anti-apoptotic (including Bcl-2 proper, Bcl-xL, and Bcl-w, among an assortment of others). There are a total of 25 genes in the Bcl-2 family known to date. Human genes encoding proteins that belong to this family include: Bak1, Bax, Bal-2, Bok, Mcl-1.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-170648
    TS-IN-5 Modulator
    TS-IN-5 (Compound 15) 是一种 thymidylate synthase (TS) 抑制剂。TS-IN-5 通过调节 BaxBCL-2PI3KSTAT1 蛋白诱导细胞凋亡 (Apoptosis)。TS-IN-5 对肝癌、乳腺癌和结肠癌具有抗肿瘤作用。
    TS-IN-5
  • HY-P5327
    r8 Bid BH3
    r8 Bid BH3 是一种有生物活性的肽。(Bid BH3 是 BCL-2 家族蛋白“仅 BH3”子集的促凋亡成员,构成细胞凋亡的关键控制点。 r8BIDBH3 对表达 Bcl-2 的人类白血病细胞系具有致死性。 Bcl-2 拮抗剂可能具有有效治疗癌症的潜力。聚-D-精氨酸(d-异构体,以 rrrrrrrr 表示)与 Bid BH3 肽融合,以促进细胞摄取该肽。)
    r8 Bid BH3
  • HY-P5325
    Bid BH3 (80-99)
    Bid BH3 (80-99) 是一种有生物活性的肽。(BID 是 BCL-2 蛋白家族“仅 BH3”(BOPS) 子集的促凋亡成员,构成细胞凋亡的关键控制点。据报道,Bid 是第一个结合并激活 Bcl-2、Bax 和 Bak 的 BOP。 Bid 是一种死亡诱导配体,从细胞质移动到线粒体膜,使 Bcl-2 失活或激活 Bax。当谷氨酰胺 (Q) 或谷氨酸 (E) 位于序列N末端。 Q或E向pGlu的转化是自然发生的,并且一般认为pGlu的疏水性γ-内酰胺环可能在针对胃肠道蛋白酶的肽稳定性中发挥作用。因此,焦谷氨酰肽被认为是此类肽的正常子集,并在 HPLC 分析期间作为肽纯度的一部分包含在内。)
    Bid BH3 (80-99)
  • HY-168953
    Lysosomal P-gp targeted agent 1 Inhibitor
    Lysosomal P-gp targeted agent 1 (Compound 14) 是一种靶向溶酶体 P-glycoprotein (Pgp) 的抗肿瘤药物。Lysosomal P-gp targeted agent 1 通过过表达的 Pgp 选择性转运到溶酶体,释放一氧化氮生成 reactive oxygen species (ROS),导致溶酶体膜透化作用 (LMP) 并诱导细胞凋亡 (apoptosis)。Lysosomal P-gp targeted agent 1 能克服 P-glycoprotein 介导的耐药性并导致细胞周期停滞,但对正常细胞的毒性相对较低。Lysosomal P-gp targeted agent 1 具有抗肿瘤活性,可显著抑制肿瘤体积。
    Lysosomal P-gp targeted agent 1
  • HY-P5341
    Bik BH3
    Bik BH3 是一种有生物活性的肽。(BIK 的 BH3 结构域)
    Bik BH3
  • HY-120275
    CYD-2-11 Agonist
    CYD-2-11 是一种选择性的 Bax 激动剂,Ki 值为 34.1 nM。CYD-2-11 诱导细胞凋亡,对 MDA-MB-231 和 MCF-7 乳腺癌细胞系具有抗增殖作用,IC50 值为 3.22 和 3.81 μM。CYD-2-11 在 MDA-MB-231 肿瘤模型中抑制肿瘤生长。CYD-2-11 可用于乳腺癌和肺癌的研究。
    CYD-2-11
  • HY-129325
    Cytochalasin H Inhibitor
    Cytochalasin H 是一种天然产物,可以从真菌 Phomopsis sp 中分离得到。Cytochalasin H 抑制细胞生长并诱导细胞凋亡 (apoptosis)。Cytochalasin H 具有抗血管生成活性。Cytochalasin H 是一种抗生素,具有抗菌活性。
    Cytochalasin H
  • HY-RS08230
    MCL1 Human Pre-designed siRNA Set A Inhibitor
    MCL1 Human Pre-designed siRNA Set A 包括针对 MCL1 (Human) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    MCL1 Human Pre-designed siRNA Set A
    MCL1 Human Pre-designed siRNA Set A
  • HY-RS01423
    Bcl2l1 Rat Pre-designed siRNA Set A Inhibitor
    Bcl2l1 Rat Pre-designed siRNA Set A 包括针对 Bcl2l1 (Rat) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Bcl2l1 Rat Pre-designed siRNA Set A
    Bcl2l1 Rat Pre-designed siRNA Set A
  • HY-154961
    Mcl-1 inhibitor 14
    Mcl-1 inhibitor 14 (Compound (Ra)-10) 是 髓系细胞白血病 -1 (MCL-1) 的抑制剂,Ki 为 0.018 nM,可用于抗癌研究。
    Mcl-1 inhibitor 14
  • HY-148203
    Mcl-1 inhibitor 9 Inhibitor
    Mcl-1 inhibitor 9 (example 2) 是一种 myeloid cell leukemia 1 (Mcl-1) 抑制剂,IC50 值为 0.21889 nM,其具有抗肿瘤活性。
    Mcl-1 inhibitor 9
  • HY-169412
    MAPK-IN-3 Inhibitor
    MAPK-IN-3 (Compound 4a) 是一种抗增殖剂,对 KYSE 30,HCT 116,HGC 27 表现出特别强的抑制作用,IC50 值分别为 0.57 μM,3.27 μM 和 2.28 μM。MAPK-IN-3 通过 p53 依赖机制阻滞细胞周期,并通过 p53 非依赖机制诱导细胞凋亡,下调了细胞周期相关蛋白 (如 Cyclin D1 和 cyclin B1) 的表达,上调了促凋亡蛋白 (如裂解 PARP、裂解 caspase-7 和裂解 caspase-9),并减少了抗凋亡蛋白 (如 Bcl-2) 的表达,增加了 KYSE 30 细胞内的 ROS 水平,并上调了与 ROS 相关的 MAPK 信号通路成员 (如 p-ERKp-p38p-JNK) 的表达。
    MAPK-IN-3
  • HY-RS08231
    Mcl1 Mouse Pre-designed siRNA Set A Inhibitor
    Mcl1 Mouse Pre-designed siRNA Set A 包括针对 Mcl1 (Mouse) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Mcl1 Mouse Pre-designed siRNA Set A
    Mcl1 Mouse Pre-designed siRNA Set A
  • HY-RS01417
    BCL2 Rat Pre-designed siRNA Set A Inhibitor
    BCL2 Rat Pre-designed siRNA Set A 包括针对 BCL2 (Rat) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    BCL2 Rat Pre-designed siRNA Set A
    BCL2 Rat Pre-designed siRNA Set A
  • HY-129159
    (-)-Clerosterol
    (-)-Clerosterol 是一种可以从 Codium fragile 中分离得到的天然产物。
    (-)-Clerosterol
  • HY-RS01416
    Bcl2 Mouse Pre-designed siRNA Set A Inhibitor
    Bcl2 Mouse Pre-designed siRNA Set A 包括针对 Bcl2 (Mouse) 基因的不同区域设计三对 siRNA,以及阴性对照、FAM 标记阴性对照和阳性对照。
    Bcl2 Mouse Pre-designed siRNA Set A
    Bcl2 Mouse Pre-designed siRNA Set A
  • HY-146444
    Anticancer agent 56 Inhibitor
    Anticancer agent 56 (compound 4d) 是一种具有类似活性分子特性的强效抗癌剂,对多种肿瘤细胞系具有抗癌活性 (IC50<3 μM)。Anticancer agent 56 诱导细胞周期阻滞在 G2/M 期,并触发线粒体凋亡通路。Anticancer agent 56 通过积累 ROS,上调 BAX,下调 Bcl-2,激活 caspases 3, 7, 9 起到抗癌作用。
    Anticancer agent 56
  • HY-155242
    VEGFR-2-IN-36 Modulator
    VEGFR-2-IN-36 (compound 15) 是一种 VEGFR-2 抑制剂 (IC50: 0.067 μM) 和凋亡 (apoptosis) 诱导剂,具有抗癌活性。VEGFR-2-IN-36 上调 BAX 的水平,下调 Bcl-2 的水平。VEGFR-2-IN-36 对癌细胞具有毒性,MCF-7 (IC50=0.42 μM) 和 HepG2 (IC50=0.22 μM)。
    VEGFR-2-IN-36
  • HY-N2575R
    Hypocrellin A (Standard)

    竹红菌甲素 (Standard)

    Hypocrellin A (Standard)是 Hypocrellin A 的分析标准品。本产品用于研究及分析应用。Hypocrellin A 是一种 PKC 抑制剂,通过逆转高糖对内皮素 (ET-1) 的表达来发挥抗糖尿病活性。Hypocrellin A 也是一种具有抗癌,抗菌和抗病毒活性,特别是针对人类免疫缺陷病毒(HIV)的光动力疗法 (PDT) 光敏剂。此外,Hypocrellin-A 还拥有抗利什曼原虫活性 (IC50=0.27
    Hypocrellin A (Standard)
  • HY-143872
    Bcl-2-IN-4 Inhibitor
    Bcl-2-IN-4 是一种有效的、具有口服活性的选择性 Bcl-2 抑制剂,IC50 为 1.5 nM。Bcl-2-IN-4 的选择性比 Bcl-xL 高于 200 倍 (IC50 为 411 nM)。Bcl-2-IN-4 抑制 RS4; 11 细胞增殖,IC50 为 2.7 nM (WO2021180040A1; compound 2)。
    Bcl-2-IN-4
目录号 产品名 / 同用名 应用 反应物种

Bcl-2 family members have been grouped into three classes. The anti-apoptotic subfamily contains the Bcl-2, Bcl-XL, Bcl-w, Mcl-1, Bfl1/A-1, and Bcl-B proteins, which suppress apoptosis and contain all four Bcl-2 homology domains, designated BH1-4. The pro-apoptotic subfamily contain BH1-3 domains, such as Bax, Bak, and Bok. A third class of BH3 only proteins Bad, Bid, Bim, Noxa and Puma have a conserved BH3 domain that can bind and regulate the anti-apoptotic BCL-2 proteins to promote apoptosis [1].


The intrinsic pathway is initiated by various signals, principally extracellular stimuli. BH3-only proteins (Bim, Bid, Bad, Noxa, Puma) engage with anti-apoptotic Bcl-2 family proteins to relieve their inhibition of Bax and Bak to activate them. Next, Bax and Bak are oligomerized and activated, leading to mitochondrial outer membrane permeabilization. Once mitochondrial membranes are permeabilized, cytochrome c and/or Smac/DIABLO is released into the cytoplasm, wherein they combine with an adaptor molecule, Apaf-1, and an inactive initiator Caspase, Pro-caspase 9, within a multiprotein complex called the apoptosome. Smac/DIABLO inhibits IAPs to activate Caspase 9. Caspase 9 activates Caspase 3, which is the initiation step for the cascade of Caspase activation. The extrinsic pathway can be activated by cell surface receptors, such as Fas and TNF Receptor, subsequently activating Caspase 8, and leads to Caspase 3 activation and cell demolition. Caspases in turn cleave a series of substrates, activate DNases and orchestrate the demolition of the cell. Bcl-2 family proteins are also found on the endoplasmic reticulum and the perinuclear membrane in hematopoietic cells, but they are predominantly localized to mitochondria [2]

 

Reference:
[1]. Cotter TG, et al. Apoptosis and cancer: the genesis of a research field. Nat Rev Cancer. 2009 Jul;9(7):501-7.

[2]. Kang MH, et al. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009 Feb 15;15(4):1126-32.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.